Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

KRX:007570 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	233,921	205,533	281,258	349,981	510,655	1,197,901
Market Cap Growth	-14.71%	-26.92%	-19.64%	-31.46%	-57.37%	191.80%
Enterprise Value	344,573	341,070	394,941	436,337	605,360	1,322,774
Last Close Price	13050.00	11410.00	15441.15	18905.81	27200.55	63349.14
PE Ratio	21.65	21.04	-	18.05	36.39	110.11
Forward PE	-	49.90	49.90	49.90	49.90	49.90
PS Ratio	0.85	0.76	1.06	1.41	2.11	3.49
PB Ratio	0.98	0.85	1.22	1.47	2.25	4.89
P/TBV Ratio	1.01	0.88	1.26	1.51	2.32	5.92
P/FCF Ratio	-	-	32.19	180.62	13.07	25.32
P/OCF Ratio	-	36.60	19.24	59.49	9.93	20.84
EV/Sales Ratio	1.25	1.27	1.48	1.76	2.50	3.85
EV/EBITDA Ratio	14.77	16.38	13.93	16.77	22.92	28.29
EV/EBIT Ratio	23.97	31.01	24.11	30.62	39.86	38.79
EV/FCF Ratio	-10.77	-	45.21	225.19	15.50	27.96
Debt / Equity Ratio	0.51	0.45	0.32	0.31	0.43	0.42
Debt / EBITDA Ratio	5.73	5.17	2.56	2.85	3.73	2.20
Debt / FCF Ratio	-	-	8.32	38.24	2.52	2.18
Asset Turnover	0.59	0.65	0.67	0.60	0.56	0.78
Inventory Turnover	2.14	2.79	2.96	3.46	3.40	3.17
Quick Ratio	0.40	0.39	0.47	0.46	0.59	0.60
Current Ratio	0.87	0.80	0.89	0.82	0.81	0.92
Return on Equity (ROE)	4.61%	4.45%	-0.87%	8.53%	6.25%	9.21%
Return on Assets (ROA)	1.65%	1.67%	2.57%	2.17%	2.21%	4.86%
Return on Capital (ROIC)	2.13%	2.11%	3.33%	2.79%	2.82%	6.10%
Return on Capital Employed (ROCE)	4.40%	4.00%	6.50%	5.50%	6.00%	13.00%
Earnings Yield	4.63%	4.99%	-0.86%	5.54%	2.75%	0.91%
FCF Yield	-13.68%	-15.85%	3.11%	0.55%	7.65%	3.95%
Dividend Yield	1.15%	1.31%	-	-	-	-
Payout Ratio	25.14%	29.00%	-	20.34%	16.74%	45.05%
Buyback Yield / Dilution	0.03%	0.26%	2.87%	-1.90%	-	-
Total Shareholder Return	1.18%	1.58%	2.87%	-1.90%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.